Live: Will Rubrik Crush Q1 Earnings Tonight and Continue Its 33% 1-Month Rally?

Health and Healthcare

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

584 Articles

Douglas A. McIntyre | Dec 5, 2007 at 12:33 PM EST

Bristol-Myers (BMY): Better Share Price Through Lay-Offs

Bristol-Myers (BMY) showed the world its equivalent of the old Soviet "Five Year Plan" today. All of the talk up…

Douglas A. McIntyre | Nov 4, 2007 at 5:28 PM EST

A Little Trouble For Bristol-Myers (BMY) Plavix

Plavix from Bristol-Myers (BMY) is the medical drug-thinner of choice. According to CNN Money, sales of the drug "totaled $3.4…

Douglas A. McIntyre | Oct 17, 2007 at 7:51 AM EDT

Medarex Hit With Sell Rating (MEDX, BMY)

Medarex (NASDAQ:MEDX) is seeing shares being hit by a research note where Banc of America initiated coverage with a "SELL"…

Douglas A. McIntyre | Oct 12, 2007 at 1:05 PM EDT

Evaluating Medarex & Bristol-Myers Huge Options Open Interest (MEDX, BMY, DNDN)

We were screening options activity today and something came up that where bets had significantly grown from our prior coverage. …

Douglas A. McIntyre | Oct 8, 2007 at 3:17 AM EDT

Media Digest 10/8/2007 Reuters, WSJ, NYTimes, FT, Barron’s

According to Reuters, Morgan Stanley (MS) plans to start a wealth management business in India. Reuters writes that Alan Greenspan…

Douglas A. McIntyre | Sep 25, 2007 at 3:08 AM EDT

Media Digest 9/25/2007 Reuters, WSJ, NYTimes, FT, Barron’s

According to Reuters, Microsoft (MSFT) launched its Halo 3 game which is essential to driving Xbox sales. Reuters writes that…

Douglas A. McIntyre | Sep 11, 2007 at 7:22 AM EDT

Imclone’s ERBITUX Extends Life in Lung Cancer Patients (IMCL, BMY, DNA)

Shares of Imclone Systems Inc. (NASDAQ:IMCL) are screaming higher this morning on it meeting its primary endpoint of increasing survival…

Douglas A. McIntyre | Aug 28, 2007 at 9:19 AM EDT

Pfizer: New Life For Lipitor As Alzheimer’s Treatment

A new medical study shows that people who take statins, cholesterol-lowering drugs, appear to be less likely to develope Alzheimer’s,…

Douglas A. McIntyre | Aug 22, 2007 at 11:04 AM EDT

IPO FILING: Adnexus Therapeutics, Targeting Avastin (ADNX, BMY)

ADNEXUS THERAPEUTICS, INC. has filed to come public via an IPO with the filed amount to sell up to $86,250,000…

Douglas A. McIntyre | Jun 25, 2007 at 6:24 AM EDT

Earlybird Analyst Calls (June 25, 2007)

Stock Tickers: ABI, BBSI, BMY, CAP, CLUB, CVX, FCBP, GM, IPG, OMC, MIG, PER, PIR, SKH, SMSI, TRLG ABI raised…

Douglas A. McIntyre | Jun 24, 2007 at 12:16 PM EDT

Mixed Short Interest in Drug & Medical Stocks (June 2007)

As you will see, the short interest changes in medical and drug stocks of the active NYSE-listed names was a…

Douglas A. McIntyre | Jun 20, 2007 at 3:20 AM EDT

Media Digest 6/20/2007 Reuters, WSJ, NYTimes, FT, Barron’s

According to Reuters, Microsoft (MSFT) will alter its Vista operating system so that it works better with Google (GOOG) and…

Douglas A. McIntyre | Jun 19, 2007 at 7:11 AM EDT

Pre-Market Stock News (June 19, 2007)

(ALTH) Allos Therapeutics trading down 20% after its Phase III study of Efaproxyn failed to meet primary endpoint of improvement…

Douglas A. McIntyre | May 22, 2007 at 4:36 PM EDT

Short Selling Up in Drug & Medical Stocks

Some sectors showed mixed results in the short selling, but the Big Pharma and medical instruments and related companies saw…

1 … 37 38 39

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Bristol-Myers (BMY): Better Share Price Through Lay-Offs

A Little Trouble For Bristol-Myers (BMY) Plavix

Medarex Hit With Sell Rating (MEDX, BMY)

Evaluating Medarex & Bristol-Myers Huge Options Open Interest (MEDX, BMY, DNDN)

Media Digest 10/8/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Media Digest 9/25/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Imclone’s ERBITUX Extends Life in Lung Cancer Patients (IMCL, BMY, DNA)

Pfizer: New Life For Lipitor As Alzheimer’s Treatment

IPO FILING: Adnexus Therapeutics, Targeting Avastin (ADNX, BMY)

Earlybird Analyst Calls (June 25, 2007)

Mixed Short Interest in Drug & Medical Stocks (June 2007)

Media Digest 6/20/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Pre-Market Stock News (June 19, 2007)

Short Selling Up in Drug & Medical Stocks

Live: Will Rubrik Crush Q1 Earnings Tonight and Continue Its 33% 1-Month Rally?

Live: Can Lululemon’s Q1 Earnings Tonight Spark a Recovery?

Billionaire Bill Ackman’s Pershing Square Exits Universal Music After Failed Takeover Bids, Stock Slumps 7%

Nvidia’s CEO Sees Marvell Becoming the Next $1 Trillion Company. Shares Gained Another 5% Today.

Wall Street Analyst: Broadcom’s Flat AI Guidance Justified the Selloff, but Nvidia Remains Best-in-Class Chip Play

Middle-Class Fortysomethings Have a $427,000 Problem and a Shrinking Window to Fix It

The $43,000-a-Year 401(k) Withdrawal That Keeps a $1.4 Million Retiree in the 12% Bracket for Life

Billionaire Bill Ackman’s Pershing Square Exits Universal Music After Failed Takeover Bids, Stock Slumps 7%

Nvidia’s CEO Sees Marvell Becoming the Next $1 Trillion Company. Shares Gained Another 5% Today.

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Bristol-Myers (BMY): Better Share Price Through Lay-Offs

A Little Trouble For Bristol-Myers (BMY) Plavix

Medarex Hit With Sell Rating (MEDX, BMY)

Evaluating Medarex & Bristol-Myers Huge Options Open Interest (MEDX, BMY, DNDN)

Media Digest 10/8/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Media Digest 9/25/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Imclone’s ERBITUX Extends Life in Lung Cancer Patients (IMCL, BMY, DNA)

Pfizer: New Life For Lipitor As Alzheimer’s Treatment

IPO FILING: Adnexus Therapeutics, Targeting Avastin (ADNX, BMY)

Earlybird Analyst Calls (June 25, 2007)

Mixed Short Interest in Drug & Medical Stocks (June 2007)

Media Digest 6/20/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Pre-Market Stock News (June 19, 2007)

Short Selling Up in Drug & Medical Stocks

Live: Will Rubrik Crush Q1 Earnings Tonight and Continue Its 33% 1-Month Rally?

Live: Can Lululemon’s Q1 Earnings Tonight Spark a Recovery?

Billionaire Bill Ackman’s Pershing Square Exits Universal Music After Failed Takeover Bids, Stock Slumps 7%

Nvidia’s CEO Sees Marvell Becoming the Next $1 Trillion Company. Shares Gained Another 5% Today.

Wall Street Analyst: Broadcom’s Flat AI Guidance Justified the Selloff, but Nvidia Remains Best-in-Class Chip Play

Featured Reads

Middle-Class Fortysomethings Have a $427,000 Problem and a Shrinking Window to Fix It

The $43,000-a-Year 401(k) Withdrawal That Keeps a $1.4 Million Retiree in the 12% Bracket for Life